Search Results - "Herrmann HC"

Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study.

Authors: Moliterno DJ Yakubov SJ DiBattiste PM et al.

Source: Lancet. 8/3/2002, Vol. 360 Issue 9330, p355-360. 6p.

Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial.

Authors: Ross MJ Herrmann HC Moliterno DJ et al.

Source: Journal of the American College of Cardiology (JACC). Sep2003, Vol. 42 Issue 6, p981-988. 8p.

Hemodynamic effects of sildenafil in men with severe coronary artery disease.

Authors: Herrmann HC Chang G Klugherz BD et al.

Source: New England Journal of Medicine. 06/01/2000, Vol. 342 Issue 22, p1622-1626. 5p.

Prevention of cardiovascular events after percutaneous coronary intervention.

Authors: Herrmann HC (AUTHOR)

Source: New England Journal of Medicine. 6/24/2004, Vol. 350 Issue 26, p2708-2710. 3p.

Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban.

Authors: Schneider DJ Herrmann HC Lakkis N et al.

Source: American Journal of Cardiology. Feb2003, Vol. 91 Issue 3, p334-336. 3p.

Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban.

Authors: Schneider DJ Herrmann HC Lakkis N et al.

Source: American Journal of Cardiology. Dec2002, Vol. 90 Issue 12, p1421-1423. 3p.

This result is not displayed to guests.
Login for full access.

Comparison of two platelet gylcoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

Authors: Topol EJ Moliterno DJ Herrmann HC et al.

Source: New England Journal of Medicine. 06/21/2001, Vol. 344 Issue 25, p1888-1894. 7p.

Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis.

Authors: Reynolds MR Magnuson EA Lei Y et al.

Source: Circulation. 11/1/2011, Vol. 124 Issue 18, p1964-1972. 9p.

Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors: Smith CR Leon MB Mack MJ et al.

Source: New England Journal of Medicine. 6/9/2011, Vol. 364 Issue 23, p2187-2198. 12p.

Late Surgical Mitral Valve Repair after Percutaneous Repair with the MitraClip((R)) System.

Authors: Rogers JH Yeo KK Carroll JD et al.

Source: Journal of Cardiac Surgery. Nov/Dec2009, Vol. 24 Issue 6, p677-681. 5p.

Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial.

Authors: Kirtane AJ Piazza G Murphy SA et al.

Source: Journal of the American College of Cardiology (JACC). Jun2006, Vol. 47 Issue 12, p2374-2379. 6p.

Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.

Authors: Gibson CM Karmpaliotis D Kosmidou I et al.

Source: American Journal of Cardiology. May2006, Vol. 97 Issue 10, p1473-1477. 5p.

Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.

Authors: Maisel AS McCord J Nowak RM et al.

Source: Journal of the American College of Cardiology (JACC). Jun2003, Vol. 41 Issue 11, p2010-2017. 8p.

A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placement.

Authors: Juergens CP White HD Belardi JA et al.

Source: Clinical Therapeutics. Aug2002, Vol. 24 Issue 8, p1332-1344. 13p.

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

Authors: Maisel AS Krishnaswamy P Nowak RM et al.

Source: New England Journal of Medicine. 7/18/2002, Vol. 347 Issue 3, p161-167. 7p.

Real-World Outcomes of Transcatheter Tricuspid Valve Replacement: Analysis From the STS/ACC TVT Registry.

Authors: Makkar RR Gupta A O'Neill BP et al.

Source: JAMA [JAMA] 2026 May 12; Vol. 335 (18), pp. 1606-1615.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

Simple Index for Identifying Patients at Increased Risk of Suboptimal Forward-Flow Hemodynamics After Transcatheter Aortic Valve Replacement.

Authors: Leone PP Regazzoli D Sturla M et al.

Source: Journal of the American Heart Association [J Am Heart Assoc] 2026 Apr 07; Vol. 15 (7), pp. e045483. Date of Electronic Publication: 2026 Mar 18.

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE

Patent Foramen Ovale Closure in Stroke and the PASCAL Classification System.

Authors: Saver JL Kent DM Kasner SE et al.

Source: JAMA neurology [JAMA Neurol] 2026 Mar 01; Vol. 83 (3), pp. 242-249.

Publication Type: Journal Article; Meta-Analysis

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE

Procedural Strategies for Optimal Transcatheter Aortic Valve Replacement: An International Position Statement.

Authors: Maznyczka A Pilgrim T Hildick-Smith D et al.

Source: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2026 Jul 13; Vol. 19 (13), pp. 1713-1734.

Publication Type: Consensus Statement; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101467004 Publication Model: Print Cited Medium: Internet ISSN: 1876-7605 (Electronic) Linking ISSN: 19368798 NLM ISO Abbreviation: JACC Cardiovasc Interv Subsets: MEDLINE